Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (33 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 19 Aug 2022 – 20 Aug 2026, limited by Bandhan Midcap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Bandhan Midcap Fund | Nifty Midcap 150 |
|---|---|---|
| 19 Aug 2022 | ₹100.00 | ₹100.00 |
| 19 Dec 2022 | ₹99.57 | ₹103.57 |
| 20 Apr 2023 | ₹98.10 | ₹100.47 |
| 20 Aug 2023 | ₹115.83 | ₹121.30 |
| 19 Dec 2023 | ₹134.19 | ₹143.89 |
| 19 Apr 2024 | ₹142.48 | ₹154.78 |
| 19 Aug 2024 | ₹174.53 | ₹182.47 |
| 19 Dec 2024 | ₹182.19 | ₹184.35 |
| 20 Apr 2025 | ₹154.16 | ₹166.08 |
| 20 Aug 2025 | ₹176.16 | ₹184.30 |
| 19 Dec 2025 | ₹174.05 | ₹189.26 |
| 20 Apr 2026 | ₹163.24 | ₹188.23 |
| 20 Aug 2026 | ₹181.58 | ₹199.88 |
| Metric | Bandhan · Regular · IDCW NAV ₹18.18 Very High risk ★★★★☆ | Category median Mid Cap Fund · 33 funds |
|---|---|---|
| +3.07% | +4.36% | |
| +16.13% | +14.16% | |
| — | +13.38% | |
| — | +7.79% | |
| +16.07% | +9.71% | |
| +13.93% | — | |
| +19.08% | +11.96% | |
| — | +10.86% | |
| — | +9.43% | |
| Risk | ||
| 16.72% | 17.59% | |
| 0.58 | 0.44 | |
| 0.78 | 0.61 | |
| -23.31% | -47.34% | |
| Nifty Midcap 150 | — | |
| -1.82% | -3.13% | |
| 1.04 | 0.97 | |
| 98.7% | 91.4% | |
| 107.9% | 102.1% | |
| 2.13% | 2.04% | |
| ₹2,155Cr | ₹9,315Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 28% | 41% | |
| Harshal Joshi | — | |
| 19 Aug 2022 | — | |
| 85 | — | |
| 27.4% | — | |
| 3.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.